Description
Capixet 500 mg is a prescription cancer medicine containing capecitabine. It belongs to a group of medicines called antineoplastic agents. Doctors use capecitabine as part of treatment plans for certain cancers, including colorectal and breast cancer.
Capixet 500 mg tablets are manufactured by Everest Pharmaceuticals Ltd., according to the product information reviewed for this page. The generic name is capecitabine. Each tablet contains 500 mg of capecitabine.
Capecitabine is an oral chemotherapy medicine. It changes into an active cancer-treatment substance called 5-fluorouracil (5-FU) inside the body. This helps interfere with the growth of certain cancer cells.
Capixet 500 mg is not suitable for everyone. The treating oncologist decides whether it is appropriate based on the cancer type, treatment plan, kidney function, and other medical factors. The dose may also change during treatment.
If you need Capixet 500 mg, use a valid prescription and confirm the medicine with a pharmacy professional. Oncology Medi can provide information about product availability, ordering requirements, and prescription verification.
The 500 mg strength refers to the amount of capecitabine in one tablet. It does not mean that every patient should take one tablet per dose.
Key Benefits and Treatment Role
Capixet 500 mg provides an oral form of chemotherapy. This means it can be taken by mouth rather than being given through an intravenous infusion.
Doctors may use capecitabine:
- As a single medicine for selected cancer treatment plans.
- With other chemotherapy medicines.
- As part of treatment for colorectal cancer.
- As part of treatment for breast cancer.
- For certain gastric, esophageal, or gastroesophageal junction cancers.
- For selected pancreatic cancer treatment plans.
The exact role depends on the cancer type, stage, previous treatment, and the oncologist’s recommendations.
Capecitabine is not a general medicine for every cancer. It should only be used for an appropriate medical indication.
Active Ingredient: Capecitabine
The active ingredient in Capixet 500 mg is capecitabine.
Capecitabine is a prodrug. A prodrug is a medicine that changes into another active substance after it enters the body. Capecitabine is converted through several steps into 5-fluorouracil, also known as 5-FU.
The active substance interferes with processes that cancer cells need to make DNA and grow. This is why capecitabine is used in certain chemotherapy regimens.
The medicine can also affect healthy cells. This explains why side effects may occur during treatment.
How Capixet 500 mg Works
Capecitabine is taken by mouth and absorbed into the body. It then undergoes conversion into active metabolites, including 5-FU.
5-FU interferes with DNA and RNA production. These processes are important for cell growth and division. Cancer cells may be affected because they often grow and divide rapidly.
Capecitabine is designed to produce active treatment effects through this conversion process. The medicine does not work in the same way as targeted medicines such as receptor tyrosine kinase inhibitors.
Treatment response varies between patients. The oncologist uses clinical examinations, scans, laboratory tests, and other assessments to monitor the treatment.
Indications and Uses
Capixet 500 mg may be prescribed for certain cancer conditions.
Colorectal Cancer
Capecitabine is used in selected patients with colon or rectal cancer. It may be prescribed alone or with other chemotherapy medicines.
Treatment can depend on whether the cancer is being treated after surgery or has spread to other parts of the body.
Breast Cancer
Capecitabine may be used for certain breast cancer treatment plans. It can be used alone or with other medicines, depending on previous treatment and the patient’s condition.
Gastric and Esophageal Cancer
Capecitabine is used in selected treatment plans for gastric cancer, esophageal cancer, and gastroesophageal junction cancer.
Pancreatic Cancer
Capecitabine may be used as part of certain pancreatic cancer chemotherapy regimens.
Important: These uses do not mean that Capixet 500 mg is suitable for every patient with these cancers. The prescribing oncologist must decide the treatment plan.
Dosage and Administration
Capixet 500 mg dosage is individual. Do not choose a dose based only on the tablet strength or another person’s prescription.
The doctor considers:
- Cancer type and treatment goal.
- Body surface area.
- Kidney function.
- Other chemotherapy medicines.
- Previous side effects.
- Laboratory test results.
- The planned treatment cycle.
Capecitabine is often given in treatment cycles. Some regimens involve taking the medicine for a set number of days followed by a rest period. Other regimens may use different schedules.
The correct schedule depends on the prescribed treatment plan.
How to Take Capixet 500 mg
Follow your oncologist’s instructions carefully.
- Take the tablets within 30 minutes after a meal.
- Swallow the tablets whole with water.
- Do not crush, chew, or break the tablets unless a qualified professional gives specific instructions.
- Take the medicine at the prescribed times.
- Do not take extra tablets if you miss a dose.
- Do not change the dose without speaking to your oncology team.
If you miss a dose, contact your treating team for instructions. Do not double the next dose.
Dose Changes
The oncologist may reduce, interrupt, or stop treatment if serious side effects occur.
Kidney function can affect capecitabine dosing. Patients with moderate renal impairment may require a lower dose. The medicine is generally not recommended in patients with severe renal impairment under standard prescribing information.
Your doctor may also request blood tests and other monitoring during treatment.
Available Strengths and Pack Sizes
Available Strength
Capixet is identified in the reviewed Bangladesh medicine listings as a 500 mg tablet.
Other capecitabine brands and strengths may exist. They are not automatically interchangeable without professional confirmation.
Available Pack Size
The reviewed Capixet listing identifies a pack of 14 tablets in an HDPE container. Confirm the actual pack size, label, and availability before ordering.
Pack sizes and stock may vary. Oncology Medi should display the current pack information only after verification.
Who Can Use This Medicine?
Capixet 500 mg may be prescribed to adults with certain cancers when the treating oncologist considers it appropriate.
Before treatment, the doctor may review:
- Cancer diagnosis and treatment history.
- Kidney and liver function.
- Blood counts.
- Current medicines.
- Previous reactions to chemotherapy.
- Pregnancy or breastfeeding status.
- Possible DPD deficiency.
Children should only receive capecitabine under the direction of an appropriate specialist.
Who Should NOT Use It?
Capixet 500 mg should not be used without medical supervision.
The medicine may be unsuitable for people with:
- A serious allergy to capecitabine or its ingredients.
- A serious allergy to fluoropyrimidine medicines.
- Complete DPD deficiency, where applicable under current prescribing guidance.
- Severe kidney impairment.
- Certain serious blood-count abnormalities.
- Other medical conditions that make treatment unsafe.
A history of severe reaction to fluorouracil or capecitabine must be discussed with the oncologist.
Do not start treatment based on an online product description alone.
Warnings and Precautions
DPD Deficiency
Some people have reduced activity of an enzyme called dihydropyrimidine dehydrogenase (DPD). This enzyme helps break down fluoropyrimidine medicines.
Complete DPD deficiency can increase the risk of severe or life-threatening toxicity from capecitabine.
Ask your treating team whether DPYD testing is appropriate before starting treatment. Testing decisions should follow current prescribing guidance and the urgency of treatment.
Kidney Problems
Capecitabine is affected by kidney function. Patients with reduced kidney function may require a dose adjustment.
Tell your doctor if you have kidney disease or changes in urination.
Dehydration
Vomiting and diarrhea can cause dehydration. Dehydration may affect kidney function and increase treatment risks.
Contact your oncology team promptly if you have severe diarrhea, repeated vomiting, or difficulty drinking fluids.
Hand-and-Foot Syndrome
Capecitabine can cause hand-and-foot syndrome. This may involve redness, swelling, tingling, pain, or skin changes on the hands and feet.
Report symptoms early. Your doctor may adjust treatment or recommend supportive care.
Bleeding Risk
Capecitabine can increase the risk of bleeding when used with certain medicines, including vitamin K antagonists such as warfarin.
Tell your doctor if you take warfarin or another blood thinner.
Pregnancy and Breastfeeding
Capecitabine may harm an unborn baby. Tell your doctor if you are pregnant, planning pregnancy, or think you may be pregnant.
Breastfeeding is generally not recommended during treatment and for the specified period after the last dose according to prescribing guidance.
Ask your oncologist about contraception and fertility concerns before treatment.
Possible Side Effects
Capixet 500 mg can cause side effects. Some are mild, while others need urgent medical attention.
Common Side Effects
Possible side effects include:
- Nausea.
- Vomiting.
- Diarrhea.
- Abdominal discomfort.
- Tiredness.
- Weakness.
- Reduced appetite.
- Mouth sores.
- Hand-and-foot syndrome.
- Skin changes.
The severity varies between patients.
Serious Side Effects
Contact your oncology team promptly if you develop:
- Severe or persistent diarrhea.
- Repeated vomiting.
- Fever or signs of infection.
- Unusual bleeding or bruising.
- Severe mouth sores.
- Painful redness or swelling of hands or feet.
- Chest pain or breathing difficulty.
- Severe skin reactions.
- Yellowing of the skin or eyes.
- Signs of dehydration.
Seek urgent medical help for severe breathing difficulty, chest pain, fainting, or other emergency symptoms.
Do not wait for your next appointment if you have serious symptoms.
Drug Interactions
Tell your doctor and pharmacist about every medicine you take.
Important interactions include:
Warfarin and Other Vitamin K Antagonists
Capecitabine may increase the effect of certain blood thinners. This can increase bleeding risk.
Your doctor may need to monitor blood clotting more frequently.
Allopurinol
Allopurinol may affect capecitabine’s active metabolites. Ask your doctor before taking these medicines together.
Other Chemotherapy Medicines
Capecitabine may be prescribed with other cancer medicines. The combination must be selected and monitored by the oncology team.
Folic Acid and Related Products
Some folic acid or folate-related products may affect fluoropyrimidine toxicity. Do not start supplements without discussing them with your treating team.
Provide a full list of prescription medicines, over-the-counter products, vitamins, and supplements.
Storage Instructions
Store Capixet 500 mg according to the product label and pharmacist’s instructions.
General storage guidance for the reviewed product includes:
- Keep in a dry place.
- Store below 30°C when consistent with the product label.
- Protect from light.
- Keep out of reach of children.
- Keep tablets in the original container.
- Do not use tablets that are damaged or past their expiry date.
Do not transfer medicine into an unlabelled container.
Why Buy From Oncology Medi?
Oncology Medi aims to help customers understand prescription medicines and make informed pharmacy inquiries.
The product page should explain the actual services available, such as:
- Product availability confirmation.
- Prescription verification.
- Manufacturer and pack information.
- Pharmacy support for ordering questions.
- Shipping information for eligible destinations.
- Clear payment and refund terms.
Only verified pharmacy credentials, sourcing claims, and delivery promises should appear on the published page.
Authenticity Guarantee
Customers should check the product name, strength, manufacturer, batch details, expiry date, and packaging before use.
Oncology Medi should provide a clear authenticity process based on its actual sourcing and verification arrangements.
If the packaging appears damaged, the label is unclear, or the product does not match the prescription, contact the pharmacy before using it.
Do not claim a product is genuine unless the pharmacy has a reliable basis for that claim.
Prescription Requirements
Capixet 500 mg is a prescription medicine.
Customers should have a valid prescription from an appropriate medical professional. The prescription should identify the medicine, strength, and directions for use.
Do not begin capecitabine treatment without an oncologist’s guidance.
A pharmacy may need to review the prescription before confirming an order. Prescription rules can vary by country and destination.
How to Order Capixet 500 mg
To inquire about Capixet 500 mg through Oncology Medi:
- Check whether the product is currently available.
- Confirm the required prescription.
- Provide the medicine name and strength.
- Submit the prescription for review through the pharmacy’s approved process.
- Confirm price, pack size, shipping terms, and delivery destination.
- Complete the order only after the pharmacy confirms the details.
Request Capixet 500 mg availability and prescription verification through Oncology Medi.
Conclusion
Capixet 500 mg contains capecitabine, an oral chemotherapy medicine used in selected cancer treatment plans. It may be prescribed for colorectal, breast, gastric, esophageal, gastroesophageal junction, or pancreatic cancer, depending on the patient’s condition.
The medicine requires careful dosing and monitoring. Kidney function, DPD deficiency, drug interactions, and side effects are important considerations.
If your oncologist has prescribed Capixet 500 mg, contact a pharmacy for product availability, prescription verification, and ordering information.
Oncology Medi can help you understand the pharmacy process and the product details before you make a purchase inquiry.
Reviews
There are no reviews yet.